Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT04076748
PHASE3

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

The analgesic treatment for vaso-occlusive crisis (VOC) in sickle-cell patients is an emergency. The reference treatment is morphine, which requires a venous way sometimes difficult to obtain in these patients. Sufentanil intranasal has been shown to be effective in traumatology. The objective is to evaluate, in VOC, the efficacy of intranasal sufentanil relayed by morphine IV compared to the usual protocol, Equimolar Mixture of Oxygen-Nitrous Oxide (EMONO) relayed by morphine intravenous (IV).

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

115

Start Date

2021-07-20

Completion Date

2024-07-21

Last Updated

2026-06-22

Healthy Volunteers

No

Interventions

DRUG

Sufentanil

The intervention is intranasal Sufentanil adminstration, then IV morphine as soon as possible.

DRUG

EMONO

In the control group, patients will receive EMONO then IV morphine as soon as possible.

Locations (8)

Hopital Pellegrin

Bordeaux, France

Hôpital Louis Mourier

Colombes, France

Gonesse Hospital

Gonesse, France

Hôpital Edouard Herriot

Lyon, France

Hôpital Charles Nicolle

Rouen, France

Hôpital Rangueil

Toulouse, France

CH de Cayenne

Cayenne, French Guiana

CHU Pointe à Pitre

Les Abymes, Guadeloupe